Tennessee Subject | Drugs, Prescription

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
TNSB2274Enroll
75%
As introduced, requires a pharmacy or other authorized dispensing person or entity to make all reasonable efforts to contact and notify a person of the lowest available cost of a prescription drug prior to the point of sale. - Amends TCA Title 47, Ch...
[Detail][Text][Discuss]
2024-04-19
Transmitted to Governor for action.
TNSB2019Enroll
75%
As introduced, increases from 50 to 100 the number of patients to whom a licensed nurse practitioner or physician assistant who is authorized to prescribe Schedule II or III drugs may prescribe buprenorphine products; increases from four to 10 the ma...
[Detail][Text][Discuss]
2024-04-17
Transmitted to Governor for action.
TNHB2897Intro
25%
As introduced, requires a pharmacy or other authorized dispensing person or entity to make all reasonable efforts to contact and notify a person of the lowest available cost of a prescription drug prior to the point of sale. - Amends TCA Title 47, Ch...
[Detail][Text][Discuss]
2024-04-15
Sponsor(s) Added.
TNHB2060Intro
25%
As introduced, increases from 50 to 100 the number of patients to whom a licensed nurse practitioner or physician assistant who is authorized to prescribe Schedule II or III drugs may prescribe buprenorphine products; increases from four to 10 the ma...
[Detail][Text][Discuss]
2024-04-11
Sponsor(s) Added.
TNSB2818Intro
25%
As introduced, extends from 10 to 14 days the period following receipt of notice from the board of pharmacy within which an owner or person in possession of drugs or devices that have been deemed misbranded or adulterated must request a show cause he...
[Detail][Text][Discuss]
2024-03-12
To Senate Commerce and Labor Committee
TNSB1683FailAs introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs int...
[Detail][Text][Discuss]
2024-02-20
Failed in Senate Commerce and Labor Committee - no second
TNSB1765FailAs introduced, requires the department of finance and administration, in collaboration with the department of health and the bureau of TennCare, to apply for federal approval to import prescription drugs from Canada; requires the department to notify...
[Detail][Text][Discuss]
2024-02-20
Failed in Senate Commerce and Labor Committee - no second
TNHB2446Intro
25%
As introduced, extends from 10 to 14 days the period following receipt of notice from the board of pharmacy within which an owner or person in possession of drugs or devices that have been deemed misbranded or adulterated must request a show cause he...
[Detail][Text][Discuss]
2024-02-01
P2C, caption bill, held on desk - pending amdt.
TNHB1956Intro
25%
As introduced, requires the department of finance and administration, in collaboration with the department of health and the bureau of TennCare, to apply for federal approval to import prescription drugs from Canada; requires the department to notify...
[Detail][Text][Discuss]
2024-01-30
Assigned to s/c Insurance Subcommittee
TNHB1737Intro
25%
As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs int...
[Detail][Text][Discuss]
2024-01-11
Assigned to s/c Insurance Subcommittee
TNHB0667PassAs enacted, makes various changes to the prescription drug donation repository program operated by the department of health. - Amends TCA Title 56; Title 63 and Title 68.
[Detail][Text][Discuss]
2023-05-03
Comp. became Pub. Ch. 200
TNSB0675PassAs enacted, makes various changes to the prescription drug donation repository program operated by the department of health. - Amends TCA Title 56; Title 63 and Title 68.
[Detail][Text][Discuss]
2023-05-03
Effective date(s) 01/01/2024
TNHB1419Intro
25%
As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription me...
[Detail][Text][Discuss]
2023-02-07
Assigned to s/c Health Subcommittee
TNSB1314Intro
25%
As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription me...
[Detail][Text][Discuss]
2023-02-06
To Senate Commerce and Labor Committee
TNSB0691Intro
25%
As introduced, removes the "within 10 days after January 1, 2015" factor from the requirement that each medical practitioner, unless the practitioner meets an exception, must ensure that the undispensed inventory of opioids and benzodiazepines purcha...
[Detail][Text][Discuss]
2023-02-02
To Senate Judiciary Committee
TNHB0266Intro
25%
As introduced, removes the "within 10 days after January 1, 2015" factor from the requirement that each medical practitioner, unless the practitioner meets an exception, must ensure that the undispensed inventory of opioids and benzodiazepines purcha...
[Detail][Text][Discuss]
2023-01-21
P2C, caption bill, held on desk - pending amdt.
Syndicate content
feedback